Entity
  • City Cancer Challenge

    Created in 2019
  • BETA

    Trend leader (A+)
    Existing signals make this entity one of the most dynamic startups
  • Social networks

    586 7,102 8,131
  • Activities

  • Entity types

  • Location

    Rue du Commerce 9, 1204 Genève, Switzerland

    Genève

    Switzerland

  • Employees

    Scale: 11-50

    Estimated: 64

  • Engaged corporates

    17
    2 15
  • Added in Motherbase

    3 years ago
Description
  • Value proposition

    We’re supporting cities around the world as they work to improve access to equitable, quality cancer care.

    City Cancer Challenge (C/Can) supports cities around the world as they work to improve access to equitable, quality cancer care. It leads a city-based partnership initiative that aims to improve access to quality cancer care in cities around the world by transforming the way stakeholders from the public and private sectors collectively design, plan, and implement cancer solutions.

    The approach is built on the core principle that cities can drive impact at national level by crafting data-driven solutions with the support of a network of global, regional, and local partners that reflect an understanding of the
    unique local context.

    C/Can was launched by the Union for International Cancer Control (UICC) at the 2017 World Economic Forum Annual Meeting in Davos. It was established as a standalone Swiss foundation in January 2019.


    Health, cancer care, Global Health, and health systems strengthening

  • City Cancer Challenge – Home – C/Can – Driving local innovation for global impact

    C/Can is a multi-sectoral cancer care initiative supporting city-led solutions in the design, planning and implementation of cancer treatment.

  • https://citycancerchallenge.org/
Corporate interactions BETA
Corporate TypeTweets Articles
PwC
PwC
Consulting, audit, IT Services and IT Consulting
PwC
Consulting, audit, IT Services and IT Consulting
Other

9 Nov 2023


MSD
MSD
Pharmaceutical, Pharmaceutical Manufacturing
MSD
Pharmaceutical, Pharmaceutical Manufacturing
Other

4 Oct 2024


Instituto de Biomecánica (IBV) Instituto de Biomecánica (IBV)
Research, footwear
Other

12 Jun 2019


Amgen
Amgen
Biotechnology, Biotechnology Research
Amgen
Biotechnology, Biotechnology Research
Other

20 May 2022

4 Oct 2024



AbbVie
AbbVie
Pharmaceutical, Pharmaceutical Manufacturing
AbbVie
Pharmaceutical, Pharmaceutical Manufacturing
Other

11 Aug 2022


Bristol Myers Squibb
Bristol Myers Squibb
Pharmaceutical, Pharmaceutical Manufacturing
Bristol Myers Squibb
Pharmaceutical, Pharmaceutical Manufacturing
Other

3 May 2021

15 Jul 2024



AstraZeneca
AstraZeneca
Pharmaceutical, Pharmaceutical Manufacturing
AstraZeneca
Pharmaceutical, Pharmaceutical Manufacturing
Other

15 Jul 2024


Sahel and West Africa Club/Club du Sahel et de l'Afrique de l'Ouest
Sahel and West Africa Club/Club du Sahel et de l'Afrique de l'Ouest
International development, International Affairs
Sahel and West Africa Club/Club du Sahel et de l'Afrique de l'Ouest
International development, International Affairs
Other

8 Oct 2020


Financial Times
Financial Times
Media, Newspaper Publishing
Financial Times
Media, Newspaper Publishing
Other

7 Jul 2015


Telefónica
Telefónica
Startup accelerator & VC, Telecommunications
Telefónica
Startup accelerator & VC, Telecommunications
Other

25 Jun 2018


Similar entities
Loading...
Loading...
Social network dynamics